Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study

Lamin A is a protein of the nuclear lamina. Low levels of lamin A expression are associated with osteosarcopenia in mice. In this study, we hypothesized that low lamin A expression is also associated with frailty in humans. We aimed to develop a non-invasive method to quantify lamin A expression in...

Full description

Autores:: Al Saedi⁠, Ahmed
Gunawardene, Piumali
Bermeo, Sandra
Vogrin, Sara
Boersma, Derek
Phu, Steven
Singh⁠, Lakshman
Suriyaarachchi, Pushpa
Duque, Gustavo

Tipo de recurso:

Fecha de publicación:: 2018

Institución:: Universidad Simón Bolívar

Repositorio:: Repositorio Digital USB

Idioma:: eng

id	USIMONBOL2_597b8f1ba6050a7128cbae84f2c84955
oai_identifier_str	oai:bonga.unisimon.edu.co:20.500.12442/1808
network_acronym_str	USIMONBOL2
network_name_str	Repositorio Digital USB
repository_id_str
dc.title.eng.fl_str_mv	Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study
title	Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study
spellingShingle	Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study Lamin A Aging Frailty COP cells Circulating osteoprogenitors Flow cytometry
title_short	Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study
title_full	Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study
title_fullStr	Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study
title_full_unstemmed	Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study
title_sort	Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study
dc.creator.fl_str_mv	Al Saedi⁠, Ahmed Gunawardene, Piumali Bermeo, Sandra Vogrin, Sara Boersma, Derek Phu, Steven Singh⁠, Lakshman Suriyaarachchi, Pushpa Duque, Gustavo
dc.contributor.author.none.fl_str_mv	Al Saedi⁠, Ahmed Gunawardene, Piumali Bermeo, Sandra Vogrin, Sara Boersma, Derek Phu, Steven Singh⁠, Lakshman Suriyaarachchi, Pushpa Duque, Gustavo
dc.subject.eng.fl_str_mv	Lamin A Aging Frailty COP cells Circulating osteoprogenitors Flow cytometry
topic	Lamin A Aging Frailty COP cells Circulating osteoprogenitors Flow cytometry
description	Lamin A is a protein of the nuclear lamina. Low levels of lamin A expression are associated with osteosarcopenia in mice. In this study, we hypothesized that low lamin A expression is also associated with frailty in humans. We aimed to develop a non-invasive method to quantify lamin A expression in epithelial and circulating osteoprogenitor (COP) cells, and to determine the relationship between lamin A expression and frailty in older individuals. COP cells and buccal swabs were obtained from 66 subjects (median age 74; 60% female; 26 non-frail, 23 pre-frail, and 17 frail) participating at the Nepean Osteoporosis and Frailty (NOF) Study. We quantified physical performance and disability, and stratified frailty in this population. Lamin A expression in epithelial and COP cells was quantified by flow cytometry. Linear regression models estimated the relationship between lamin A expression in buccal and COP cells, and prevalent disability and frailty. Lamin A expression in buccal cells showed no association with either disability or frailty. Low lamin A expression values in COP cells were associated with frailty. Frail individuals showed 60% lower levels of lamin A compared to non-frail (95% CI − 36 to − 74%, p < 0.001) and 62% lower levels compared to pre-frail (95%CI − 40 to − 76%, p < 0.001). In summary, we have identified lamin A expression in COP cells as a strong indicator of frailty. Further work is needed to understand lamin A expression as a risk stratifier, biomarker, or therapeutic target in frail older persons.
publishDate	2018
dc.date.accessioned.none.fl_str_mv	2018-03-07T22:37:28Z
dc.date.available.none.fl_str_mv	2018-03-07T22:37:28Z
dc.date.issued.none.fl_str_mv	2018-02
dc.type.spa.fl_str_mv	article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.identifier.issn.none.fl_str_mv	05315565
dc.identifier.uri.none.fl_str_mv	http://hdl.handle.net/20.500.12442/1808
identifier_str_mv	05315565
url	http://hdl.handle.net/20.500.12442/1808
dc.language.iso.spa.fl_str_mv	eng
language	eng
dc.rights.coar.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.license.spa.fl_str_mv	Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional
rights_invalid_str_mv	Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional http://purl.org/coar/access_right/c_abf2
dc.publisher.eng.fl_str_mv	Elsevier
dc.source.eng.fl_str_mv	Experimental Gerontology Vol. 102 (2018)
institution	Universidad Simón Bolívar
dc.source.uri.none.fl_str_mv	https://www.sciencedirect.com/science/article/pii/S0531556517307428?via%3Dihub
bitstream.url.fl_str_mv	https://bonga.unisimon.edu.co/bitstreams/95962147-1846-4a62-8859-90302169920a/download
bitstream.checksum.fl_str_mv	8a4605be74aa9ea9d79846c1fba20a33
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	DSpace UniSimon
repository.mail.fl_str_mv	bibliotecas@biteca.com
_version_	1812100522004447232
spelling	Licencia de Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacionalhttp://purl.org/coar/access_right/c_abf2Al Saedi⁠, Ahmedf83ed6a8-7bc6-41be-92aa-bf9350104cf3-1Gunawardene, Piumali4f64fa86-c6d8-4ef5-b4fa-751fcccb8ea6-1Bermeo, Sandra5adcb3ad-0b9f-41f8-8a5f-a4d6086d31ef-1Vogrin, Sara806a44b8-9f2a-491f-b91b-5796665f7cbd-1Boersma, Derek5295ef81-cfd1-4b34-8a20-14c07ab4bab7-1Phu, Stevenc0787bef-53f4-43cd-8857-98d4634a6341-1Singh⁠, Lakshman4ff473d1-8cc5-4594-8db8-b6ccb19fad11-1Suriyaarachchi, Pushpade4aafc6-f489-4964-8864-fd332b5e5fa0-1Duque, Gustavof99ef41b-e311-4165-bbc4-73e084153d5f-12018-03-07T22:37:28Z2018-03-07T22:37:28Z2018-0205315565http://hdl.handle.net/20.500.12442/1808Lamin A is a protein of the nuclear lamina. Low levels of lamin A expression are associated with osteosarcopenia in mice. In this study, we hypothesized that low lamin A expression is also associated with frailty in humans. We aimed to develop a non-invasive method to quantify lamin A expression in epithelial and circulating osteoprogenitor (COP) cells, and to determine the relationship between lamin A expression and frailty in older individuals. COP cells and buccal swabs were obtained from 66 subjects (median age 74; 60% female; 26 non-frail, 23 pre-frail, and 17 frail) participating at the Nepean Osteoporosis and Frailty (NOF) Study. We quantified physical performance and disability, and stratified frailty in this population. Lamin A expression in epithelial and COP cells was quantified by flow cytometry. Linear regression models estimated the relationship between lamin A expression in buccal and COP cells, and prevalent disability and frailty. Lamin A expression in buccal cells showed no association with either disability or frailty. Low lamin A expression values in COP cells were associated with frailty. Frail individuals showed 60% lower levels of lamin A compared to non-frail (95% CI − 36 to − 74%, p < 0.001) and 62% lower levels compared to pre-frail (95%CI − 40 to − 76%, p < 0.001). In summary, we have identified lamin A expression in COP cells as a strong indicator of frailty. Further work is needed to understand lamin A expression as a risk stratifier, biomarker, or therapeutic target in frail older persons.engElsevierExperimental GerontologyVol. 102 (2018)https://www.sciencedirect.com/science/article/pii/S0531556517307428?via%3DihubLamin AAgingFrailtyCOP cellsCirculating osteoprogenitorsFlow cytometryLamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Studyarticlehttp://purl.org/coar/resource_type/c_6501Ahmed, N., Mandel, R., Fain, M.J., 2007. Frailty: an emerging geriatric syndrome. Am. J. Med. 120, 748–753.Akter, R., Rivas, D., Geneau, G., Drissi, H., Duque, G., 2009. Effect of lamin A/C knockdown on osteoblast differentiation and function. J. Bone Miner. Res. 24, 283–293.Bermeo, S., Vidal, C., Zhou, H., Duque, G., 2015. Lamin A/C acts as an essential factor in mesenchymal stem cell differentiation through the regulation of the dynamics of the Wnt/β-catenin pathway. J. Cell. Biochem. 116, 2344–2353.Calvani, R., Marini, F., Cesari, M., Tosato, M., Picca, A., Anker, S.D., von Haehling, S., Miller, R.R., Bernabei, R., Landi, F., Marzetti, E., SPRINTT Consortium, 2017. Biomarkers for physical frailty and sarcopenia. Aging Clin. Exp. Res. 29, 29–34.Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373–383.Clegg, A., Young, J., Iliffe, S., Rikkert, M.O., Rockwood, K., 2013. Frailty in elderly people. Lancet 381, 752–762.De Martinis, M., Franceschi, C., Monti, D., Ginaldi, L., 2006. Inflammation markers predicting frailty and mortality in the elderly. Exp. Mol. Pathol. 80, 219–227.De Sandre-Giovannoli, A., Bernard, R., Cau, P., Navarro, C., Amiel, J., Boccaccio, I., Lyonnet, S., Stewart, C.L., Munnich, A., Le Merrer, M., Lévy, N., 2003. Lamin A truncation in Hutchinson-Gilford progeria. Science 300, 2055.Duque, G., Rivas, D., 2006. Age-related changes in lamin A/C expression in the osteoarticular system: laminopathies as a potential new aging mechanism. Mech. Ageing Dev. 127, 378–383.Duque, G., Li, W., Yeo, L.S., Vidal, C., Fatkin, D., 2011. Attenuated anabolic response to exercise in lamin A/C haploinsufficient mice. Bone 49, 412–418.Egan, K.P., Kim, J.H., Mohler 3rd, E.R., Pignolo, R.J., 2011. Role for circulating osteogenic precursor cells in aortic valvular disease. Arterioscler. Thromb. Vasc. Biol. 31, 2965–2971.Fillenbaum, G.G., Smyer, M.A., 1981. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J. Gerontol. 36, 428–434.Fougère, B., Boulanger, E., Nourhashémi, F., Guyonnet, S., Cesari, M., 2016. Chronic inflammation: accelerator of biological aging. J. Gerontol. A Biol. Sci. Med. Sci. (Dec 21).Fried, L.P., Ferrucci, L., Darer, J., Williamson, J.D., Anderson, G., 2004. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J. Gerontol. A Biol. Sci. Med. Sci. 59, 255–263.Golpanian, S., DiFede, D.L., Pujol, M.V., Lowery, M.H., Levis-Dusseau, S., Goldstein, B.J., Schulman, I.H., Longsomboon, B., Wolf, A., Khan, A., Heldman, A.W., Goldschmidt- Clermont, P.J., Hare, J.M., 2016. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: a phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty. Oncotarget 7, 11899–11912.Gonzalo, S., Kreienkamp, R., Askjaer, P., 2017. Hutchinson-Gilford progeria syndrome: a premature aging disease caused by LMNA gene mutations. Ageing Res. Rev. 33, 18–29.Gruenbaum, Y., Margalit, A., Goldman, R.D., Shumaker, D.K., Wilson, K.L., 2005. The nuclear lamina comes of age. Nat. Rev. Mol. Cell Biol. 6, 21–31.Gunawardene, P., Bermeo, S., Vidal, C., Al-Saedi, A., Chung, P., Boersma, D., Phu, S., Pokorski, I., Suriyaarachchi, P., Demontiero, O., Duque, G., 2016. Association between circulating osteogenic progenitor cells and disability and frailty in older persons: the Nepean osteoporosis and frailty study. J. Gerontol. A Biol. Sci. Med. Sci. 71, 1124–1130.Gunawardene, P., Al Saedi, A., Singh, L., Bermeo, S., Vogrin, S., Phu, S., Suriyaarachchi, P., Pignolo, R.J., Duque, G., 2017. Age, gender, and percentage of circulating osteoprogenitor (COP) cells: the COP study. Exp. Gerontol. 96, 68–72.Horvath, A.R., Kis, E., Dobos, E., 2010. Guidelines for the use of biomarkers: principles, processes and practical considerations. Scand. J. Clin. Lab. Investig. Suppl. 242, 109–111.Huang, W., Sowa, G., 2011. Biomarker development for musculoskeletal diseases. PM R. 3 (6 Suppl 1), S39–44.Hutchison, C.J., Worman, H.J., 2004. A-type lamins: guardians of the soma. Nat. Cell Biol. 6, 1062–1067.Joseph, C., Kenny, A.M., Taxel, P., Lorenzo, J.A., Duque, G., Kuchel, G.A., 2005. Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol. Asp. Med. 26, 181–201.Korf, B., 2008. Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina. N. Engl. J. Med. 358, 552–555.Li, W., Yeo, L.S., Vidal, C., McCorquodale, T., Herrmann, M., Fatkin, D., Duque, G., 2011. Decreased bone formation and osteopenia in lamin a/c-deficient mice. PLoS One 6, e19313.Mahoney, F., Barthel, D., 1965. Functional evaluation: the Barthel index. Md Med. J. 14, 61–65.Morley, J.E., Haren, M.T., Rolland, Y., Kim, M.J., 2006. Frailty. Med. Clin. North Am. 90, 837–847.Pajerowski, J.D., Dahl, K.N., Zhong, F.L., Sammak, P.J., Discher, D.E., 2007. Physical plasticity of the nucleus in stem cell differentiation. Proc. Natl. Acad. Sci. U. S. A. 104, 15619–15624.de Paula Rodrigues, G.H., das Eiras Tamega, I., Duque, G., Spinola Dias Neto, V., 2002. Severe bone changes in a case of Hutchinson-Gilford syndrome. Ann. Genet. 45, 151–155.Pignolo, R.J., Kassem, M., 2011. Circulating osteogenic cells: implications for injury, repair, and regeneration. J. Bone Miner. Res. 26, 1685–1693.Ritt, M., Rádi, K.H., Schwarz, C., Bollheimer, L.C., Sieber, C.C., Gaßmann, K.G., 2016. A comparison of frailty indexes based on a comprehensive geriatric assessment for the prediction of adverse outcomes. J. Nutr. Health Aging 20, 760–767.Rodríguez-Mañas, L., Féart, C., Mann, G., Viña, J., Chatterji, S., Chodzko-Zajko, W., Gonzalez- Colaço Harmand, M., Bergman, H., Carcaillon, L., Nicholson, C., Scuteri, A., Sinclair, A., Pelaez, M., Van der Cammen, T., Beland, F., Bickenbach, J., Delamarche, P., Ferrucci, L., Fried, L.P., Gutiérrez-Robledo, L.M., Rockwood, K., Rodríguez Artalejo, F., Serviddio, G., Vega, E., FOD-CC group, 2013. Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition- consensus conference project. J. Gerontol. A Biol. Sci. Med. Sci. 68, 62–67.Searle, S.D., Mitnitski, A., Gahbauer, E.A., Gill, T.M., Rockwood, K., 2008. A standard procedure for creating a frailty index. BMC Geriatr. 8, 24.Soysal, P., Stubbs, B., Lucato, P., Luchini, C., Solmi, M., Peluso, R., Sergi, G., Isik, A.T., Manzato, E., Maggi, S., Maggio, M., Prina, A.M., Cosco, T.D., YT, Wu, Veronese, N., 2016. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res. Rev. 31, 1–8.Tong, J., Li, W., Vidal, C., Yeo, L.S., Fatkin, D., Duque, G., 2011. Lamin A/C deficiency is associated with fat infiltration of muscle and bone. Mech. Ageing Dev. 132, 552–559.Vidal, C., Bermeo, S., Fatkin, D., Duque, G., 2012. Role of the nuclear envelope in the pathogenesis of age-related bone loss and osteoporosis. Bonekey Rep. 2 (1), 62.de Vries, N.M., Staal, J.B., van Ravensberg, C.D., Hobbelen, J.S., Olde Rikkert, M.G., Nijhuis- van der Sanden, M.W., 2010. Outcome instruments to measure frailty: a systematic review. Ageing Res. Rev. 10, 104–114.Walston, J., Hadley, E.C., Ferrucci, L., Guralnik, J.M., Newman, A.B., Studenski, S.A., Ershler, W.B., Harris, T., Fried, L.P., 2006. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on frailty in older adults. J. Am. Geriatr. Soc. 54, 991–1001.Wilson, D., Jackson, T., Sapey, E., Lord, J.M., 2017. Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res. Rev. 36, 1–10.Xue, Q.L., 2011. The frailty syndrome: definition and natural history. Clin. Geriatr. Med. 27, 1–15.LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bonga.unisimon.edu.co/bitstreams/95962147-1846-4a62-8859-90302169920a/download8a4605be74aa9ea9d79846c1fba20a33MD5220.500.12442/1808oai:bonga.unisimon.edu.co:20.500.12442/18082019-04-11 21:51:42.056metadata.onlyhttps://bonga.unisimon.edu.coDSpace UniSimonbibliotecas@biteca.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

Lamin A expression in circulating osteoprogenitors as a potential biomarker for frailty: The Nepean Osteoporosis and Frailty (NOF) Study

Publicaciones similares